Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.14% year-on-year.
Fairly Valued
The company’s latest PE is -26.04, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.64M shares, decreasing 24.17% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 810.18K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.62.